Reflux esophagitis triggered after helicobacter pylori eradication: A noteworthy demerit of eradication therapy among the Japanese?

Frontiers in Microbiology

Volumn 6, Issue JUN, 2015, Pages

  Iijima, Katsunori ^a   Koike, Tomoyuki ^a   Shimosegawa, Tooru ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Eradication; Gastric acid; Gerd; H. pylori; Reflux esophagitis

Indexed keywords

PROTON PUMP INHIBITOR;

ARTICLE; BACTERIAL CLEARANCE; ERADICATION THERAPY; GASTROESOPHAGEAL REFLUX; GEOGRAPHIC DISTRIBUTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HIATUS HERNIA; HUMAN; JAPANESE (PEOPLE); MARGINAL ZONE LYMPHOMA; META ANALYSIS (TOPIC); MORBIDITY; NONHUMAN; PEPTIC ULCER; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REFLUX ESOPHAGITIS; RISK ASSESSMENT; STOMACH ACID SECRETION; STOMACH CANCER; STOMACH PH;

BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI;

EID: 84936997800     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2015.00566     Document Type: Article

References (38)

1. Abe, Y., Koike, T., Iijima, K., Imatani, A., Ishida, K., Yuki, T., et al. (2011). Esophageal Adenocarcinoma Developing after Eradication of Helicobacter pylori. Case Rep. Gastroenterol. 5, 355-360. doi: 10.1159/000329878
2. Abe, Y., Ohara, S., Koike, T., Sekine, H., Iijima, K., Kawamura, M., et al. (2004). The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barrett's esophagus in Japan. Am. J. Gastroenterol. 99, 1213-1221. doi: 10.1111/j.1572-0241.2004.30313.x
3. Asaka, M. (2013). A new approach for elimination of gastric cancer deaths in Japan. Int. J. Cancer 132, 1272-1276. doi: 10.1002/ijc.27965
4. Atherton, J. C., and Blaser, M. J. (2009). Coadaptation of Helicobacter pylori and humans: ancient history, modern implications. J. Clin. Invest. 119:2475-2487. doi: 10.1172/JCI38605
5. Blaser, M. J. (2010). Helicobacter pylori and esophageal disease: wake-up call? Gastroenterology 139, 1819-1822. doi: 10.1053/j.gastro.2010.10.037
6. Fischbach, L. A., Nordenstedt, H., Kramer, J. R., Gandhi, S., Dick-Onuoha, S., Lewis, A., et al. (2012). The association between Barrett's esophagus and Helicobacter pylori infection: a meta-analysis. Helicobacter 17, 163-175. doi: 10.1111/j.1523-5378.2011.00931.x
7. Ford, A. C., Forman, D., Hunt, R. H., Yuan, Y., and Moayyedi, P. (2014). Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials. BMJ 348:g3174. doi: 10.1136/bmj.g3174
8. Fuccio, L., Zagari, R. M., Eusebi, L. H., Laterza, L., Cennamo, V., Ceroni, L., et al. (2009). Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann. Intern. Med. 151, 121-128. doi: 10.7326/0003-4819-151-2-200907210-00009
9. Fukase, K., Kato, M., Kikuchi, S., Inoue, K., Uemura, N., Okamoto, S., et al. (2008). Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 372, 392-397. doi: 10.1016/S0140-6736(08)61159-9
10. Fukuchi, T., Ashida, K., Yamashita, H., Kiyota, N., Tsukamoto, R., Takahashi, H., et al. (2005). Influence of cure of Helicobacter pylori infection on gastric acidity and gastroesophageal reflux: study by 24-h pH monitoring in patients with gastric or duodenal ulcer. J. Gastroenterol. 40, 350-360. doi: 10.1007/s00535-004-1552-1
11. Hamada, H., Haruma, K., Mihara, M., Kamada, T., Yoshihara, M., Sumii, K., et al. (2000). High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis. Aliment. Pharmacol. Ther. 14, 729-735. doi: 10.1046/j.1365-2036.2000.00758.x
12. Iijima, K., Koike, T., Abe, Y., Ohara, S., Nakaya, N., and Shimosegawa, T. (2014). Time series analysis of gastric acid secretion over a 20-year period in normal Japanese men. J. Gastroenterol. doi: 10.1007/s00535-014-1031-2. [Epub ahead of print].
13. Iijima, K., Ohara, S., Koike, T., Sekine, H., and Shimosegawa, T. (2004b). Gastric acid secretion of normal Japanese subjects in relation to H. pylori infection, aging, and gender. Scand. J. Gastroenterol. 39, 709-716. doi: 10.1080/00365520410005911
14. Iijima, K., Ohara, S., Sekine, H., Koike, T., Kato, K., Asaki, S., et al. (2000). Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylori eradication. Gut 46, 20-26. doi: 10.1136/gut.46.1.20
15. Iijima, K., Sekine, H., Koike, T., Imatani, A., Ohara, S., and Shimosegawa, T. (2004a). Long-term effect of Helicobacter pylori eradication on the reversibility of acid secretion in profound hypochlorhydria. Aliment. Pharmacol. Ther. 19, 1181-1188. doi: 10.1111/j.1365-2036.2004.01948.x
16. Inomata, Y., Koike, T., Ohara, S., Abe, Y., Sekine, H., Iijima, K., et al. (2006). Preservation of gastric acid secretion may be important for the development of gastroesophageal junction adenocarcinoma in Japanese people, irrespective of the H. pylori infection status. Am. J. Gastroenterol. 101, 926-933. doi: 10.1111/j.1572-0241.2006.00497.x
17. Inoue, H., Imoto, I., Taguchi, Y., Kuroda, M., Nakamura, M., Horiki, N., et al. (2004). Reflux esophagitis after eradication of Helicobacter pylori is associated with the degree of hiatal hernia. Scand. J. Gastroenterol. 39, 1061-1065. doi: 10.1080/00365520410008006
18. Ishiki, K., Mizuno, M., Take, S., Nagahara, Y., Yoshida, T., Yamamoto, K., et al. (2004). Helicobacter pylori eradication improves pre-existing reflux esophagitis in patients with duodenal ulcer disease. Clin. Gastroenterol. Hepatol. 2, 474-479. doi: 10.1016/S1542-3565(04)00165-X
19. Katelaris, P. H., Seow, F., Lin, B. P., Napoli, J., Ngu, M. C., and Jones, D. B. (1993). Effect of age, Helicobacter pylori infection, and gastritis with atrophy on serum gastrin and gastric acid secretion in healthy men. Gut 34, 1032-1037. doi: 10.1136/gut.34.8.1032
20. Kawanishi, M. (2005). Development of reflux esophagitis following Helicobacter pylori eradication. J. Gastroenterol. 40, 1024-1028. doi: 10.1007/s00535-005-1685-x
21. Koike, T., Ohara, S., Sekine, H., Iijima, K., Abe, Y., Kato, K., et al. (2001a). Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion. Gut. 49, 330-334. doi: 10.1136/gut.49.3.330
22. Koike, T., Ohara, S., Sekine, H., Iijima, K., Kato, K., Toyota, T., et al. (2001b). Increased gastric acid secretion after Helicobacter pylori eradication may be a factor for developing reflux oesophagitis. Aliment. Pharmacol. Ther. 15, 813-820. doi: 10.1046/j.1365-2036.2001.00988.x
23. Labenz, J., Blum, A. L., Bayerdörffer, E., Meining, A., Stolte, M., and Börsch, G. (1997). Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 112, 1442-1447. doi: 10.1016/S0016-5085(97)70024-6
24. Lee, Y. C., Chen, T. H., Chiu, H. M., Shun, C. T., Chiang, H., Liu, T. Y., et al. (2013). The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention. Gut 62, 676-682. doi: 10.1136/gutjnl-2012-302240
25. Ma, J. L., Zhang, L., Brown, L. M., Li, J. Y., Shen, L., Pan, K. F., et al. (2012). Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst. 104, 488-492. doi: 10.1093/jnci/djs003
26. McColl, K. E. (2004). Review article: Helicobacter pylori and gastro-oesophageal reflux disease-the European perspective. Aliment. Pharmacol. Ther. 20(Suppl. 8), 36-39. doi: 10.1111/j.1365-2036.2004.02227.x
27. Minatsuki, C., Yamamichi, N., Shimamoto, T., Kakimoto, H., Takahashi, Y., Fujishiro, M., et al. (2013). Background factors of reflux esophagitis and non-erosive reflux disease: a cross-sectional study of 10,837 subjects in Japan. PLoS ONE 8:e69891. doi: 10.1371/journal.pone.0069891
28. Nam, S. Y., Choi, I. J., Ryu, K. H., Kim, B. C., Kim, C. G., and Nam, B. H. (2010). Effect of Helicobacter pylori infection and its eradication on reflux esophagitis and reflux symptoms. Am. J. Gastroenterol. 105, 2153-2162. doi: 10.1038/ajg.2010.251
29. Peterson, W. L., Barnett, C. C., Evans, D. J. Jr., Feldman, M., Carmody, T., Richardson, C., et al. (1993). Acid secretion and serum gastrin in normal subjects and patients with duodenal ulcer: the role of Helicobacter pylori. Am. J. Gastroenterol. 88, 2038-2043.
30. Raghunath, A., Hungin, A. P., Wooff, D., and Childs, S. (2003). Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. BMJ 326:737. doi: 10.1136/bmj.326.7392.737
31. Raghunath, A. S., Hungin, A. P., Wooff, D., and Childs, S. (2004). Systematic review: the effect of Helicobacter pylori and its eradication on gastro-oesophageal reflux disease in patients with duodenal ulcers or reflux oesophagitis. Aliment. Pharmacol. Ther. 20, 733-744. doi: 10.1111/j.1365-2036.2004.02172.x
32. Rokkas, T., Pistiolas, D., Sechopoulos, P., Robotis, I., and Margantinis, G. (2007). Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis. Clin. Gastroenterol. Hepatol. 5, 1413-1417. doi: 10.1016/j.cgh.2007.08.010
33. Saad, A. M., Choudhary, A., and Bechtold, M. L. (2012). Effect of Helicobacter pylori treatment on gastroesophageal reflux disease (GERD): meta-analysis of randomized controlled trials. Scand. J. Gastroenterol. 47, 129-135. doi: 10.3109/00365521.2011.648955
34. Take, S., Mizuno, M., Ishiki, K., Nagahara, Y., Yoshida, T., Yokota, K., et al. (2009). Helicobacter pylori eradication may induce de novo, but transient and mild, reflux esophagitis: Prospective endoscopic evaluation. J. Gastroenterol. Hepatol. 24, 107-113. doi: 10.1111/j.1440-1746.2008.05606.x
35. Wang, C., Yuan, Y., and Hunt, R. H. (2009). Helicobacter pylori infection and Barrett's esophagus: a systematic review and meta-analysis. Am. J. Gastroenterol. 104, 492-500. doi: 10.1038/ajg.2008.37
36. Xie, F. J., Zhang, Y. P., Zheng, Q. Q., Jin, H. C., Wang, F. L., Chen, M., et al. (2013b). Helicobacter pylori infection and esophageal cancer risk: an updated meta-analysis. World J. Gastroenterol. 19, 6098-6107. doi: 10.3748/wjg.v19.i36.6098
37. Xie, T., Cui, X., Zheng, H., Chen, D., He, L., and Jiang, B. (2013a). Meta-analysis: eradication of Helicobacter pylori infection is associated with the development of endoscopic gastroesophageal reflux disease. Eur. J. Gastroenterol. Hepatol. 25, 1195-1205. doi: 10.1097/meg.0b013e328363e2c7
38. Yaghoobi, M., Farrokhyar, F., Yuan, Y., and Hunt, R. H. (2010). Is there an increased risk of GERD after Helicobacter pylori eradication?: a meta-analysis. Am. J. Gastroenterol. 105, 1007-1013. doi: 10.1038/ajg.2009.734